from our AZ-104 Phase 2a proof-of-concept clinical trial," said James V. Cassella, PhD, Senior Vice President, Research and Development at Alexza. due to the scientific rationale that loxapine's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback